Orion Healthcare Equity Partners logo

Orion Healthcare Equity Partners

North America, Massachusetts, United States, Boston

Description

Orion Healthcare Equity Management is a Venture Capital Firm focussed on health.

Investor Profile

Orion Healthcare Equity Partners has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series A (67%)
  • Seed (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Orion Healthcare Equity Partners frequently co-invest with?

Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 1
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
JDRF (The Juvenile Diabetes Research Foundation)
North America, New York, United States, New York
Co-Investments: 1
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 2
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Partners Innovation Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2

Which angels does Orion Healthcare Equity Partners often collaborate with?

HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1

What are some of recent deals done by Orion Healthcare Equity Partners?

AnTolRx

Cambridge, Massachusetts, United States

Our lead program addresses significant unmet needs in the field of Type 1 Diabetes

BiotechnologyHealth Care
Series ASep 8, 2016
Amount Raised: $4,000,000
Lysosomal Therapeutics

Cambridge, Massachusetts, United States

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

BiotechnologyHealth CareTherapeutics
Series AFeb 3, 2015
Amount Raised: $20,000,000
Lysosomal Therapeutics

Cambridge, Massachusetts, United States

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

BiotechnologyHealth CareTherapeutics
SeedMay 12, 2014
Amount Raised: $4,800,000

Find More Investors Like Orion Healthcare Equity Partners

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Orion Healthcare Equity Partners | Pipeseed